Optimal Fluid Resuscitation for Trauma Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Kenneth Proctor, University of Miami
ClinicalTrials.gov Identifier:
NCT00527098
First received: September 6, 2007
Last updated: February 20, 2013
Last verified: February 2013
Results First Received: April 1, 2011  
Study Type: Observational
Study Design: Observational Model: Case Control;   Time Perspective: Prospective
Condition: Trauma

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Hextend Plus Standard of Care Hextend along with the routine Standard of Care Resuscitation Fluid
Standard of Care Routine Standard of Care Resuscitation Fluid

Participant Flow:   Overall Study
    Hextend Plus Standard of Care     Standard of Care  
STARTED     36     83  
COMPLETED     36     83  
NOT COMPLETED     0     0  



  Baseline Characteristics
  Hide Baseline Characteristics

Reporting Groups
  Description
Hextend Plus Standard of Care Hextend along with the routine Standard of Care Resuscitation Fluid
Standard of Care Routine Standard of Care Resuscitation Fluid
Total Total of all reporting groups

Baseline Measures
    Hextend Plus Standard of Care     Standard of Care     Total  
Number of Participants  
[units: participants]
  36     83     119  
Age  
[units: participants]
     
<=18 years     0     0     0  
Between 18 and 65 years     36     83     119  
>=65 years     0     0     0  
Age  
[units: years]
Mean ± Standard Deviation
  39  ± 17     39  ± 17     39  ± 17  
Gender  
[units: participants]
     
Female     7     17     24  
Male     29     66     95  
Region of Enrollment  
[units: participants]
     
United States     36     83     119  



  Outcome Measures

1.  Primary:   Mortality   [ Time Frame: From hospital arrival up to an average of 3.5 weeks ]


  Serious Adverse Events


  Other Adverse Events


  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Limitations and Caveats
Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.  


Results Point of Contact:  
Name/Title: Kenneth Proctor, PhD
Organization: University of Miami
phone: 305-243-4694
e-mail: kproctor@med.miami.edu


Publications:

Responsible Party: Kenneth Proctor, University of Miami
ClinicalTrials.gov Identifier: NCT00527098     History of Changes
Other Study ID Numbers: 20070108
Study First Received: September 6, 2007
Results First Received: April 1, 2011
Last Updated: February 20, 2013
Health Authority: United States: Institutional Review Board